SciELO - Scientific Electronic Library Online

 
vol.68 número3Condiciones de transporte de medicamentos en misiones internacionales de las Fuerzas Armadas: Diseño de un estudio de estabilidad especifico para operaciones índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Sanidad Militar

versão impressa ISSN 1887-8571

Resumo

VALENTIN QUIROGA, J. et al. Kill the Killers: Natural Killer cells therapy against paediatric refractory solid tumours. Sanid. Mil. [online]. 2012, vol.68, n.3, pp.141-146. ISSN 1887-8571.  https://dx.doi.org/10.4321/S1887-85712012000300003.

Introduction: Refractory solid tumours lead children deaths. To change this statement, new treatments should be developed. Natural Killer cells constitute the first line of defence against tumour cells. We propose a new strategy for antitumor cell therapy in children with refractory solid malignancies: IL-15 stimulated NK cells. Patients and methods: 22 paediatric patients suffering refractory solid tumours participate in this study. We compare NK cell subsets and K562 cytotoxicity in patients and sex-age pair's healthy controls. We use multiparametric flow and time-resolved fluorescent, respectively. In immunocompromised mice we developed an aggressive human metastatic neuroblastoma model and IL-15 stimulated NK cells rescue. Results: Patients had higher NK bright cells subset and lower NK cytotoxicity than healthy controls. IL-15 stimulated NK cells improved NK cell cytotoxicity in vitro and decreased tumour burden in vivo. Conclusions: IL-15 stimulated NK cells may constitute a new cell therapy tool for paediatric refractory tumours.

Palavras-chave : Natural Killer cells (NK); interleucina 15 (IL-15); refractory solid tumours.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )

 

Creative Commons License Todo o conteúdo deste periódico, exceto onde está identificado, está licenciado sob uma Licença Creative Commons